Zenith rejects $5 million proposal with proceeds estimated below $4 million
Zenith Minerals has rejected an unsolicited $5 million capital-raising proposal from Aurenne, saying it is incomplete, difficult to implement and offers shareholders no direct consideration. The board has kept its recommendation of Forrestania Resources’ takeover offer unchanged.
- Aurenne proposal would raise $5 million through rights issue or placement
- Zenith says the proposal is non-binding and lacks key pricing terms
- Estimated net proceeds could fall to $3.55 million after costs
- Aurenne’s stake could rise from 11.1% to about 19.5%
- Zenith will not engage with Aurenne under the transaction deed
Add us as a preferred source on Google
Zenith Rejects Aurenne’s $5 Million Proposal
Zenith Minerals Limited (ASX:ZNC) has shut down a competing $5 million capital-raising proposal from Aurenne Group Holdings, leaving Forrestania Resources’ takeover offer as the company’s recommended path.
Aurenne’s unsolicited, non-binding indicative offer, received by the Zenith board on 2 October, proposed either a fully underwritten renounceable rights issue or a placement of new Zenith shares. Aurenne is an associate of Ida Metal Investments, which holds about 11.1% of Zenith.
The board said the proposal was incomplete and did not meet the transaction implementation deed’s test for a “Superior Proposal”. It determined, after receiving written advice from Hamilton Locke and Argonaut, that the proposal was neither reasonably capable of being valued and implemented nor more favourable to non-associated shareholders than Forrestania’s offer.
Unpriced Capital Raising Carries Approval Risk
The proposal leaves several important terms unresolved, including the rights issue price, entitlement ratio, underwriting fee and shortfall arrangements. The placement price would be based on a future 10-day volume-weighted average price, meaning the number of new shares, the resulting dilution and Aurenne’s eventual voting power could not yet be determined.
Zenith also pointed to the takeover mechanics. Issuing shares during the offer period could constitute a prescribed occurrence under the deed and may raise frustrating-action concerns under Takeovers Panel guidance. Shareholder approval would likely be required, but the board said the available approval pathway and any voting exclusions remain uncertain.
Break Fee Would Cut Into Funding
Even if the proposal could be implemented, Zenith said it would leave materially less than $5 million available to the business. Terminating the deed or changing the board’s recommendation would trigger a $750,000 break fee payable to Forrestania, excluding GST. Zenith estimated net proceeds of $3.55 million to $3.75 million from the rights issue, or $3.85 million to $3.95 million from the placement, after adviser fees and other transaction costs.
The board also argued that the capital raising would provide no payment, premium or other consideration to existing shareholders, unlike the scrip consideration under Forrestania’s takeover offer. Under an illustrative placement at 7.5 cents a share, Aurenne and its associates could increase their voting power to about 19.5%, while other shareholders would face dilution of approximately 9.4%.
Zenith said the proposal could therefore shift influence towards Aurenne without a control premium and leave the company with two large shareholders, Forrestania and Aurenne’s associates, without a clear control outcome. The board has concluded that the restrictions in its transaction deed continue to apply and will not engage with Aurenne on the proposal.
The decision does not change the Zenith directors’ recommendation of Forrestania’s takeover offer. A further supplementary target’s statement is expected in response to the Takeovers Panel’s final orders made on 17 September, while the unresolved question is whether Aurenne returns with a binding proposal containing terms that can actually be valued and put to shareholders.
Bottom Line?
Zenith has preserved the existing takeover path, but the control contest is not necessarily over: the next test is whether Aurenne can produce a binding, fully specified alternative before the process advances.
Questions in the middle?
- Will Aurenne return with a binding proposal that addresses pricing, approvals and dilution?
- How will the Takeovers Panel’s final orders affect the remaining takeover process?
- Can Forrestania’s offer proceed to a clear control outcome while Aurenne remains a significant shareholder?
Sources
1-
Fourth Supplementary Target's Statement (opens in a new tab)Verified source. Zenith Minerals Limited · 5 Oct 2026